BSE Live
Oct 24, 16:01Prev. Close
1376.00
Open Price
1381.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 24, 15:57Prev. Close
1376.60
Open Price
1370.00
Bid Price (Qty.)
1347.90 (13)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Tatva Chintan Pharma Chem (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 23.39 | 23.39 | 22.17 | 22.17 | 20.09 | |
| Total Share Capital | 23.39 | 23.39 | 22.17 | 22.17 | 20.09 | |
| Reserves and Surplus | 697.92 | 702.49 | 482.62 | 446.71 | 141.85 | |
| Total Reserves and Surplus | 697.92 | 702.49 | 482.62 | 446.71 | 141.85 | |
| Total Shareholders Funds | 721.31 | 725.88 | 504.78 | 468.88 | 161.94 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.64 | 4.23 | 13.11 | 26.76 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 2.08 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.02 | 1.43 | |
| Long Term Provisions | 1.40 | 1.33 | 1.15 | 0.65 | 0.55 | |
| Total Non-Current Liabilities | 1.40 | 1.97 | 5.38 | 13.78 | 30.82 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 36.39 | 13.63 | 166.03 | 106.83 | 49.29 | |
| Trade Payables | 32.31 | 44.26 | 31.61 | 44.06 | 47.04 | |
| Other Current Liabilities | 30.97 | 28.96 | 46.73 | 18.53 | 20.48 | |
| Short Term Provisions | 0.42 | 0.36 | 0.33 | 0.18 | 0.11 | |
| Total Current Liabilities | 100.09 | 87.21 | 244.70 | 169.60 | 116.93 | |
| Total Capital And Liabilities | 822.80 | 815.07 | 754.86 | 652.25 | 309.68 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 525.54 | 426.52 | 195.75 | 159.30 | 120.35 | |
| Intangible Assets | 3.12 | 0.35 | 0.48 | 0.32 | 0.10 | |
| Capital Work-In-Progress | 21.54 | 72.93 | 230.74 | 51.49 | 9.81 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 552.97 | 503.41 | 426.97 | 211.10 | 130.26 | |
| Non-Current Investments | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | |
| Deferred Tax Assets [Net] | 12.25 | 12.30 | 12.36 | 8.71 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 5.39 | 5.09 | 3.40 | 2.60 | 0.30 | |
| Total Non-Current Assets | 571.29 | 521.46 | 443.39 | 223.08 | 131.22 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 10.05 | 0.00 | 0.00 | 0.00 | |
| Inventories | 123.30 | 144.11 | 151.45 | 160.69 | 68.36 | |
| Trade Receivables | 76.16 | 67.95 | 90.04 | 61.60 | 90.34 | |
| Cash And Cash Equivalents | 11.93 | 36.97 | 38.58 | 174.74 | 3.59 | |
| Short Term Loans And Advances | 0.24 | 0.24 | 0.17 | 0.16 | 1.93 | |
| OtherCurrentAssets | 39.89 | 34.28 | 31.22 | 31.98 | 14.24 | |
| Total Current Assets | 251.52 | 293.61 | 311.47 | 429.17 | 178.46 | |
| Total Assets | 822.80 | 815.07 | 754.86 | 652.25 | 309.68 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 17.17 | 29.96 | 19.19 | 79.05 | 4.11 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | -82.41 | 72.20 | 240.93 | 164.39 | 66.25 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 219.10 | 287.59 | 322.89 | 364.20 | 163.88 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 12.05 | 12.05 | 12.05 | 12.05 | 12.05 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | 10.05 | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
03.09.2025
Sell Tatva Chintan Pharma Chem; target of Rs 860: Deven Choksey
25.07.2025
Tatva Chintan Consolidated June 2025 Net Sales at Rs 116.86 crore, up 10.81% Y-o-Y
25.07.2025
Tatva Chintan Standalone June 2025 Net Sales at Rs 109.18 crore, up 16.39% Y-o-Y
06.05.2025
Buy Tatva Chintan Pharma Chem; target of Rs 1,000: ICICI Securities
25.07.2025
Tatva Chintan Consolidated June 2025 Net Sales at Rs 116.86 crore, up 10.81% Y-o-Y
25.07.2025
Tatva Chintan Standalone June 2025 Net Sales at Rs 109.18 crore, up 16.39% Y-o-Y
05.05.2025
Tatva Chintan Consolidated March 2025 Net Sales at Rs 107.86 crore, up 9.77% Y-o-Y
05.05.2025
Tatva Chintan Standalone March 2025 Net Sales at Rs 107.65 crore, up 14.6% Y-o-Y